AISLING CAPITAL III LP [Rocket]

Date Filed	Type	Description
02/15/2019	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/15/2019	SC 13D/A	AISLING CAPITAL III LP reports a 6.7% stake in Loxo Oncology, Inc.
07/12/2018	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/05/2018	SC 13D/A	AISLING CAPITAL III LP reports a 3.1% stake in TransEnterix, Inc.
02/07/2018	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2018	SC 13G/A	AISLING CAPITAL III LP reports a 0% stake in T2 Biosystems, Inc.
02/07/2018	SC 13G/A	AISLING CAPITAL III LP reports a 4.4% stake in Aimmune Therapeutics, Inc.
02/01/2018	SC 13D/A	AISLING CAPITAL III LP reports a 1.9% stake in Pernix Therapeutics Holdings, Inc.
02/01/2018	SC 13D/A	AISLING CAPITAL III LP reports a 3.8% stake in Agile Therapeutics, Inc.
11/28/2017	SC 13D/A	AISLING CAPITAL III LP reports a 12.3% stake in Loxo Oncology, Inc.
05/09/2017	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/03/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/03/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/03/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
01/12/2017	SC 13D/A	Loxo Oncology, Inc. reports a 16.4% stake in Loxo Oncology, Inc.
10/27/2016	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
10/03/2016	SC 13D/A	AISLING CAPITAL III LP reports a 7.9% stake in Agile Therapeutics, Inc.
02/05/2016	SC 13G/A	Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/05/2016	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
11/01/2011	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership